FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

15364411000001103: Etonogestrel 11.7mg / Ethinylestradiol 2.7mg vaginal delivery system 3 system (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
53950301000001115 Etonogestrel 11.7mg / Ethinylestradiol 2.7mg vaginal delivery system 3 system (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
60253701000001113 Ethinylestradiol 2.7mg / Etonogestrel 11.7mg vaginal delivery system 3 system en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

5 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Etonogestrel 11.7mg / Ethinylestradiol 2.7mg vaginal delivery system 3 system Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Etonogestrel 11.7mg / Ethinylestradiol 2.7mg vaginal delivery system 3 system Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Etonogestrel 11.7mg / Ethinylestradiol 2.7mg vaginal delivery system 3 system VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Etonogestrel 11.7mg / Ethinylestradiol 2.7mg vaginal delivery system 3 system VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Etonogestrel 11.7mg / Ethinylestradiol 2.7mg vaginal delivery system 3 system Has VMP Etonogestrel 11.7mg / Ethinylestradiol 2.7mg vaginal delivery system true Inferred relationship Existential restriction modifier
Etonogestrel 11.7mg / Ethinylestradiol 2.7mg vaginal delivery system 3 system Has specific active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier
Etonogestrel 11.7mg / Ethinylestradiol 2.7mg vaginal delivery system 3 system Has specific active ingredient Etonogestrel true Inferred relationship Existential restriction modifier
Etonogestrel 11.7mg / Ethinylestradiol 2.7mg vaginal delivery system 3 system Has dispensed dose form Vaginal delivery system true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (CST Pharma Ltd) 3 system Is a True Etonogestrel 11.7mg / Ethinylestradiol 2.7mg vaginal delivery system 3 system Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (DE Pharmaceuticals) 3 system Is a True Etonogestrel 11.7mg / Ethinylestradiol 2.7mg vaginal delivery system 3 system Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (Organon Pharma (UK) Ltd) 3 system Is a True Etonogestrel 11.7mg / Ethinylestradiol 2.7mg vaginal delivery system 3 system Inferred relationship Existential restriction modifier
NuvaRing 0.12mg/0.015mg per day vaginal delivery system (Waymade Healthcare Plc) 3 system Is a True Etonogestrel 11.7mg / Ethinylestradiol 2.7mg vaginal delivery system 3 system Inferred relationship Existential restriction modifier
Ethinylestradiol 2.7mg / Etonogestrel 11.7mg vaginal delivery system (Colorama Pharmaceuticals Ltd) 3 system Is a False Etonogestrel 11.7mg / Ethinylestradiol 2.7mg vaginal delivery system 3 system Inferred relationship Existential restriction modifier
Ethinylestradiol 2.7mg / Etonogestrel 11.7mg vaginal delivery system (Ennogen Healthcare Ltd) 3 system Is a False Etonogestrel 11.7mg / Ethinylestradiol 2.7mg vaginal delivery system 3 system Inferred relationship Existential restriction modifier
SyreniRing 0.12mg/0.015mg per day vaginal delivery system (Crescent Pharma Ltd) 3 system Is a True Etonogestrel 11.7mg / Ethinylestradiol 2.7mg vaginal delivery system 3 system Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start